RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)
Condition(s):HIV InfectionsLast Updated:January 16, 2014Withdrawn
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:January 16, 2014Withdrawn
Condition(s):Periodontal DiseaseLast Updated:September 12, 2013Completed
Condition(s):Stage I Esophageal Adenocarcinoma; Stage II Esophageal Adenocarcinoma; Stage III Esophageal Adenocarcinoma; Stage I Esophageal Squamous Cell Carcinoma; Stage II Esophageal Squamous Cell Carcinoma; Stage III Esophageal Squamous Cell CarcinomaLast Updated:December 11, 2015Unknown status
Condition(s):Healthy VolunteerLast Updated:August 28, 2019Completed
Condition(s):PeriodontitisLast Updated:January 23, 2014Completed
Condition(s):PericoronitisLast Updated:December 10, 2019Unknown status
Condition(s):Chronic PeriodontitisLast Updated:February 26, 2019Unknown status
Condition(s):HealthyLast Updated:September 11, 2020Completed
Condition(s):Periodontal Diseases; Chronic Periodontitis; Periodontal Attachment LossLast Updated:January 28, 2016Completed
Condition(s):Recurrent Prostate CancerLast Updated:November 18, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.